[HTML][HTML] Antisense oligonucleotides in therapy for neurodegenerative disorders

MM Evers, LJA Toonen… - Advanced drug delivery …, 2015 - Elsevier
Antisense oligonucleotides are synthetic single stranded strings of nucleic acids that bind to
RNA and thereby alter or reduce expression of the target RNA. They can not only reduce …

Prions: protein aggregation and infectious diseases

A Aguzzi, AM Calella - Physiological reviews, 2009 - journals.physiology.org
Transmissible spongiform encephalopathies (TSEs) are inevitably lethal neurodegenerative
diseases that affect humans and a large variety of animals. The infectious agent responsible …

Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer

APDA Bom, LP Rangel, DCF Costa… - Journal of Biological …, 2012 - ASBMB
Over 50% of all human cancers lose p53 function. To evaluate the role of aggregation in
cancer, we asked whether wild-type (WT) p53 and the hot-spot mutant R248Q could …

Prion-like aggregation of mutant p53 in cancer

JL Silva, CVDM Gallo, DCF Costa, LP Rangel - Trends in biochemical …, 2014 - cell.com
p53 is a master regulatory protein that participates in cellular processes such as apoptosis,
DNA repair, and cell cycle control. p53 functions as a homotetrameric tumor suppressor, and …

Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

EV Minikel, HT Zhao, J Le, J O'Moore… - Nucleic acids …, 2020 - academic.oup.com
Lowering of prion protein (PrP) expression in the brain is a genetically validated therapeutic
hypothesis in prion disease. We recently showed that antisense oligonucleotide (ASO) …

[HTML][HTML] Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection

A Vaillant - Antiviral research, 2016 - Elsevier
Antiviral polymers are a well-studied class of broad spectrum viral attachment/entry
inhibitors whose activity increases with polymer length and with increased amphipathic …

[HTML][HTML] Antisense oligonucleotides extend survival of prion-infected mice

GJ Raymond, HT Zhao, B Race, LD Raymond… - JCI insight, 2019 - ncbi.nlm.nih.gov
Prion disease is a fatal, incurable neurodegenerative disease of humans and other
mammals caused by conversion of cellular prion protein (PrP C) into a self-propagating …

A systematic review of prion therapeutics in experimental models

CR Trevitt, J Collinge - Brain, 2006 - academic.oup.com
Prion diseases are transmissible, invariably fatal, neurodegenerative diseases which
include Creutzfeldt–Jakob disease (CJD) in humans and bovine spongiform …

Prions and their partners in crime

B Caughey, GS Baron - Nature, 2006 - nature.com
Prions, the infectious agents of transmissible spongiform encephalopathies (TSEs), have
defied full characterization for decades. The dogma has been that prions lack nucleic acids …

Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies

AN Khan, RH Khan - International Journal of Biological Macromolecules, 2022 - Elsevier
Most of the cell's chemical reactions and structural components are facilitated by proteins.
But proteins are highly dynamic molecules, where numerous modifications or changes in the …